Publications


ESR8 and ESR3: Goubert D; Beckman W; Verschure PJ; Rots MG Epigenetic Editing: towards realization of the curable genome concept. Convergent Science Physical Oncology (accepted manuscript), https:/doi.org/10.1088/2057-1739aa5cc0
ESR8: Song J, Cano Rodriguez D, Winkle M, Gjaltema RA, Goubert D, Jurkowski TP, Heijink IH, Rots MG, Hylkema MN. Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2016 Dec 23:ajplung.00059.2016. doi: 10.1152/ajplung.00059.2016.-
ESR4: Magnani L, Frigè G, Gadaleta RM, Corleone G, Fabris S, Kempe H, Verschure PJ, Barozzi I, Vircillo V, Hong SP, Perone Y, Saini M, Trumpp A, Viale G, Neri A, Ali S, Colleoni MA, Pruneri G, Minucci S. Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer. Nat Genet. 2017 Jan 23. doi: 10.1038/ng.3773
ESR8, book chapter: Stolzenburg S, Goubert D, Rots MG. Rewriting Dna Methylation Signatures At Will: The Curable Genome Within Reach? Advances In Experimental Medicine And Biology, 945, 475-490. DOI: 10.1007/978-3-319-43624-1_17-